Published in Eur J Clin Nutr on December 01, 2004
Familial hypercholesterolemia: A review. Ann Pediatr Cardiol (2014) 0.91
Effect of a plant sterol, fish oil and B vitamin combination on cardiovascular risk factors in hypercholesterolemic children and adolescents: a pilot study. Nutr J (2013) 0.81
[Finnish descendants in the municipality of Sor-Varanger--II. An investigation of blood pressure, height, weight, cholesterol, triglycerides and lipoproteins among Finnish descendant men--and the effect of a diet change]. Tidsskr Nor Laegeforen (1974) 2.33
Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet (2001) 2.08
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia. Eur J Clin Pharmacol (1994) 2.04
A heritable syndrome of craniosynostosis, short thin hair, dental abnormalities, and short limbs: cranioectodermal dysplasia. J Pediatr (1977) 1.71
Carotid intima-media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects. Eur J Clin Invest (1998) 1.48
Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr (1996) 1.47
Dietary phytosterols as cholesterol-lowering agents in humans. Can J Physiol Pharmacol (1997) 1.41
Fluid endocytosis in isolated rat parenchymal and non-parenchymal liver cells. Exp Cell Res (1980) 1.33
Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol (1996) 1.19
Autosomal dominant partial lipodystrophy associated with Rieger anomaly, short stature, and insulinopenic diabetes. Am J Med Genet (1983) 1.18
Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria. Hum Mol Genet (1997) 1.13
Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice. Am J Cardiol (2000) 1.10
Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I. Am J Cardiol (1999) 1.10
Fine mapping of a gene responsible for regulating dietary cholesterol absorption; founder effects underlie cases of phytosterolaemia in multiple communities. Eur J Hum Genet (2001) 1.07
Neonatal screening for hyperlipidaemia. Postgrad Med J (1975) 1.05
Reproducibility and validity of a short food questionnaire for the assessment of dietary habits. Nutr Metab Cardiovasc Dis (2002) 0.97
Phytosterolaemia in a Norwegian family: diagnosis and characterization of the first Scandinavian case. Scand J Clin Lab Invest (1996) 0.97
Evaluation of running conditions for SSCP analysis: application of SSCP for detection of point mutations in the LDL receptor gene. PCR Methods Appl (1993) 0.92
Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects. Scand J Clin Lab Invest (2006) 0.89
Standardization of a flow cytometric method for measurement of low-density lipoprotein receptor activity on blood mononuclear cells. Cytometry (1995) 0.88
Paediatric screening for hypercholesterolaemia in Europe. Arch Dis Child (2011) 0.88
Uptake and degradation of 125I-labelled high density lipoproteins in rat liver cells in vivo and in vitro. Biochim Biophys Acta (1979) 0.86
Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects. Atherosclerosis (1994) 0.86
The binding of high density lipoproteins to isolated rat hepatocytes. Scand J Clin Lab Invest (1981) 0.85
Dietary n-6 fatty acids inhibit the incorporation of dietary n-3 fatty acids in thrombocyte and serum phospholipids in humans: a controlled dietetic study. Scand J Clin Lab Invest (1991) 0.85
A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol (2000) 0.84
Results of intensive long-term treatment of familial hypercholesterolemia. Am J Cardiol (1996) 0.84
A novel variant of lysosomal acid lipase (Leu336-->Pro) associated with acid lipase deficiency and cholesterol ester storage disease. Arterioscler Thromb Vasc Biol (1995) 0.83
Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives. Pediatr Res (1996) 0.83
Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia. Hum Genet (1995) 0.83
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia. Nutr Metab Cardiovasc Dis (2000) 0.82
Intracellular degradation of 125I-labelled asialo-glycoproteins in rat hepatocytes: effect of leupeptin on subcellular distribution of asialo-fetuin. Int J Biochem (1981) 0.82
Familial hypercholesterolaemia caused by a non-sense mutation in codon 329 of the LDL receptor gene. Scand J Clin Lab Invest (1994) 0.81
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels. Am J Cardiol (2000) 0.81
Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects. Eur J Clin Invest (2003) 0.81
Determinants of lipid levels among children with heterozygous familial hypercholesterolemia in Norway. Arterioscler Thromb Vasc Biol (1995) 0.81
[Identification of syndromes using a combined computer and video program]. Tidsskr Nor Laegeforen (1990) 0.81
Catabolism of (125-I)low density lipoproteins in isolated rat liver cells. Biochem Biophys Res Commun (1980) 0.81
Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects. Am J Med (2001) 0.80
Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies. Am J Cardiol (1998) 0.80
Molecular genetics of familial hypercholesterolaemia in Norway. J Intern Med (1997) 0.80
Prophylactiv use of propranolol in the Marfan syndrome to prevent aortic dissection. Birth Defects Orig Artic Ser (1977) 0.80
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I. J Lipid Res (1997) 0.80
Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine beta-synthase deficiency: relationship between genotype and phenotype. Am J Med Genet (2001) 0.79
The effect of ammonia, chloroquine, leupeptin, colchicine and cytochalasin B on degradation of high density lipoproteins in isolated rat hepatocytes. Exp Cell Res (1980) 0.79
Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system. Arterioscler Thromb (1991) 0.79
Binding, uptake, and degradation of 125I-labelled high-density lipoproteins in isolated non-parenchymal rat liver cells. Scand J Gastroenterol (1981) 0.79
The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine. J Pediatr (1998) 0.79
Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein. J Lipid Res (1996) 0.79
Flow cytometric measurement of low density lipoprotein receptor activity validated by DNA analysis in diagnosing heterozygous familial hypercholesterolemia. Cytometry (1997) 0.79
Screening for familial hypercholesterolaemia in relatives. Lancet (1995) 0.78
Hyperlipidemia: clinical clues in the first two decades of life. Johns Hopkins Med J (1977) 0.78
Efficacy and safety of 300 micrograms and 400 micrograms cerivastatin once daily in patients with primary hypercholesterolaemia: a multicentre, randomized, double-blind, placebo-controlled study. J Int Med Res (1999) 0.78
Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER. Int J Clin Pract (2014) 0.78
Mutant transcripts of the LDL receptor gene: mRNA structure and quantity. Hum Mutat (1999) 0.78
omega-3 fatty acids decrease endothelial adhesion of human colorectal carcinoma cells. J Surg Res (2000) 0.78
Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia. J Intern Med (2012) 0.78
Under-reporting of dietary intake by smoking and non-smoking subjects counselled for hypercholesterolaemia. J Intern Med (1999) 0.78
Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia. Eur J Clin Pharmacol (1992) 0.78
The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein (a) levels in familial hypercholesterolemia. Metabolism (1996) 0.78
Increased inflammatory markers in children with familial hypercholesterolaemia. Eur J Clin Invest (2006) 0.77
No effect of beta-carotene supplementation on the susceptibility of low density lipoprotein to in vitro oxidation among hypercholesterolaemic, postmenopausal women. Scand J Clin Lab Invest (1995) 0.77
Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine. Eur J Clin Pharmacol (1994) 0.77
Serum cholesterol response to replacing butter with a new trans-free margarine in hypercholesterolemic subjects. Nutr Metab Cardiovasc Dis (2001) 0.77
A 9.6 kilobase deletion in the low density lipoprotein receptor gene in Norwegian familial hypercholesterolemia subjects. Clin Genet (1992) 0.77
Effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women. Eur J Clin Invest (1996) 0.77
Phenotypic consequences of a deletion of exons 2 and 3 of the LDL receptor gene. J Lipid Res (1999) 0.77
Low dose colestipol in adolescents with familial hypercholesterolaemia. Arch Dis Child (1996) 0.77
Does maternal or paternal heredity affect carotid atherosclerosis in children with familial hypercholesterolaemia? Acta Paediatr (2000) 0.77
Effect of Norwegian fish powder on risk factors for coronary heart disease among hypercholesterolemic individuals. Nutr Metab Cardiovasc Dis (2000) 0.77
Screening for point mutations in exon 10 of the low density lipoprotein receptor gene by analysis of single-strand conformation polymorphisms: detection of a nonsense mutation-FH469-->Stop. Hum Genet (1993) 0.76
Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women. J Intern Med (1995) 0.76
[Application of gene technology in the diagnosis of familial hypercholesterolemia]. Tidsskr Nor Laegeforen (1997) 0.76
Two novel missense mutations in the LDL receptor gene causing familial hypercholesterolemia. Clin Genet (1996) 0.76
Neonatal osteomyelitis caused by group B streptococci. Scand J Infect Dis (1976) 0.76
Effect of large-volume liposuction on sex hormones and glucose- and lipid metabolism in females. Aesthetic Plast Surg (1995) 0.76
Altered composition of HDL3 in FH subjects causing a HDL subfraction with less atheroprotective function. Clin Chim Acta (2005) 0.76
A common missense mutation (C210G) in the LDL receptor gene among Norwegian familial hypercholesterolemia subjects. Hum Mutat (1996) 0.76
Uptake of chylomicron remnant retinyl esters in human leukocytes in vivo. Eur J Clin Invest (1992) 0.75
[Familial hypercholesterolemia--prognosis and treatment]. Tidsskr Nor Laegeforen (2001) 0.75
Two novel point mutations in the EGF precursor homology domain of the LDL receptor gene causing familial hypercholesterolemia. Hum Genet (1995) 0.75
Letter: Usefulness of the xylose test for coeliac disease. Arch Dis Child (1976) 0.75
[Genetic screening and treatment in familial hypercholesterolemia]. Tidsskr Nor Laegeforen (2001) 0.75
Effects of a 9.6-kb deletion of the LDL receptor gene (FH Helsinki) on structure and levels of mRNA. Hum Mutat (1998) 0.75
[D-xylose tolerance in malabsorption. Method of determination of D-xylose in serum and urine]. Tidsskr Nor Laegeforen (1973) 0.75
Modification of low density lipoprotein in relation to intake of fatty acids and antioxidants. World Rev Nutr Diet (1994) 0.75
[Diet therapy of hypercholesterolemia. Can the diet of persons who already follow a cholesterol-lowering diet be further improved by guidelines given by a clinical nutritionist?]. Tidsskr Nor Laegeforen (1994) 0.75
[What happens with patients after participation in a clinical trial?]. Tidsskr Nor Laegeforen (1997) 0.75
Identification of the apo B-3500 mutation in the Norwegian population. Scand J Clin Lab Invest (1995) 0.75
[Diet and lipid status in pregnant women]. Tidsskr Nor Laegeforen (1995) 0.75
[Is there a need for genetic/molecular diagnosis of familial hypercholesterolemia?]. Tidsskr Nor Laegeforen (1997) 0.75
Short report on DNA marker at candidate locus. Clin Genet (1993) 0.75
Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group. Am J Cardiol (1995) 0.75
[A comparison between lovastatin and pravastatin--effects on lipids, sleep and quality of life in primary hyperlipidemia]. Tidsskr Nor Laegeforen (1994) 0.75
[Diagnosis and treatment of severe hyperlipidemia]. Tidsskr Nor Laegeforen (1997) 0.75
[Iron status in postmenopausal women]. Tidsskr Nor Laegeforen (1994) 0.75
[Referrals to the Lipid clinic--"appropriate" patients with inadequate anamnesis]. Tidsskr Nor Laegeforen (1998) 0.75
Is dietary intervention effective in post-transplant hyperlipidaemia? Nephrol Dial Transplant (1995) 0.75
Haplotype analysis at the low density lipoprotein receptor locus in normal and familial hypercholesterolemia Norwegian subjects. Clin Genet (1993) 0.75
Effectiveness of low-dose lovastatin combined with low-dose colestipol in moderate to severe primary hypercholesterolaemia. Scand J Clin Lab Invest (1993) 0.75